REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

13 Jul 2015 07:00

RNS Number : 7840S
Kuala Limited
13 July 2015
 



7.00am 13 July 2015

 

KUALA LIMITED

("Kuala" or the" Company")

 

 

APPOINTMENT OF NEW DIRECTOR

 

 

 

 

Kuala Limited, the AIM-traded, investment company is pleased to announce the appointment of James ("Jim") Mellon as an executive director with immediate effect.

 

Jim Mellon is an entrepreneur with interests in a number of sectors. After leaving Oxford, where he studied Philosophy, Politics and Economics, he worked in Asia and the United States in two fund management companies, GT Management and Thornton Management (Asia) Limited, before founding Regent Pacific Group Limited in 1991, subsequently quoted on the Hong Kong Stock Exchange. He was also a co-founder of UraMin Inc. and Red Dragon Resources, both mining groups. 

 

Jim spends most of his time developing start-up opportunities in undervalued sectors, currently concentrating on life sciences, robotics and fintech. He is also the co-author of four books: "Wake Up!", "The Top 10 Investments for the Next Ten Years", "Cracking the Code" and "Fast Forward". In addition, Jim is Chairman of Plethora Solutions Holdings plc, Manx Financial Group plc and Port Erin BioPharma Investments Limited, and a non-executive director of Charlemagne Capital Limited, Condor Gold plc, and West African Minerals Corporation, all listed on AIM. He is also a director of Portage Biotech Inc. and Miraculins Inc., both quoted in Canada.

 

Jim lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

 

Further information is disclosed in Appendix 1 below.

 

For further information please visit www.kualalimited.com or contact:

 

 

James Biddle (Nomad)

Beaumont Cornish LimitedTel: +44 207 628 3396

 

Peterhouse Corporate Finance Limited

Guy Miller/ Lucy Williams

Tel: +44 (0) 207 469 0930

Elysium Fund Management Limited

PO Box 650

1st Floor

Royal Chambers

St Peter Port

Guernsey

GY1 3JX

 

Tel: +44 1481 810 100

Fax: +44 1481 810 120

e-mail: elysium@elysiumfundman.com

 

 

 

Appendix 1: Further information on Jim Mellon

 

The information required to be disclosed in accordance with Schedule Two (g) of the AIM Rules for Companies for Mr. Mellon is set out below.

 

Jim Mellon

 

James Mellon, aged 57, is or has been in the past five years a director of the following companies:

 

Current directorships

Past directorships (in the last 5 years) 

3Legs Resources plc

Biggene Limited

Binary (IOM) Limited

Binary Holdings Limited

Burnbrae Charlottenburg GmbH

Burnbrae Commercial GmbH

Burnbrae Friedrichstein GmbH

Burnbrae Germany East GmbH

Burnbrae Germany GmbH

Burnbrae Germany North GmbH

Burnbrae Germany South GmbH

Burnbrae Germany West GmbH

Burnbrae Group Limited

Burnbrae Kreutzberg GmbH

Burnbrae Limited

Burnbrae Lutzowstrasse GmbH

Burnbrae Mitte GmbH

Burnbrae Prinzlauer Berg GmbH

Burnbrae Residential GmbH

Burnbrae Sachsen GmbH

Burnbrae Schonefeld GmbH

Burnbrae Spandau GmbH

Burnbrae Tempelhof GmbH

Burnbrae Tiergarten GmbH

Burnbrae Wedding GmbH

Burnbrae Wilmersdorf GmbH

Charlemagne Capital (IOM) Limited

Charlemagne Capital Limited

Clean Air Capital Limited

Condor Gold plc

Discover Investment Company - Discover Asia

Discover Investment Company - Discover Europe

Extreme Opportunities Limited

Ferrum Limited

Fixed-Odds Capital (Cook Islands) Ltd

Fruitful Publications Limited

Global Glory Investment Limited

IC Technology (UK) Limited

J2 Music Limited

Mann Bioinvest (BVI) Limited

Mann Bioinvest Limited

Manx Financial Group plc

Mediq Ventures Limited

Microcap Partners Limited

Plethora Solutions Holdings plc

Podenco Global Limited

Port Erin BioPharma Investments Limited

Portage Biotech Inc.

Regent Corporate Finance Limited

Regent Fund Management (Asia) Limited

Regent Fund Management Limited

Regent Metals Holdings Ltd

Regent Pacific Group Limited

Rivington Street Holdings plc

Shaanxi Red Dragon Resources Ltd

Shellbay Investments Limited

Sleepwell Hotels (UK) Limited

Sleepwell Hotels Limited

Speymill Deutsch Immobilien plc

Speymill Group plc (renamed Speymill plc)

West African Minerals Corporation

Asian Opportunity Fund 1998- Series 1

Burnbrae Development GmbH

Brazilian Gold Corporation

CCEC Limited

Cytox Limited

Genseq Limited

Miraculins Inc

Polo Resources Limited

Speymill Property Managers Limited

Summit Therapeutics plc

Venturex Resources

 

Further disclosures

 

Jim Mellon is the beneficial owner of Galloway Limited ("Galloway"). Galloway, following the announcement of 3 June 2015, has an interest of 4,551,229 ordinary shares representing 14.66% of the Company's issued share capital and also provides investment advice to Kuala under an "arms-length" contract.

 

The Company has been informed by Mr. Mellon that there is an arrest warrant in his name which was originally issued by the South Korean prosecutor's office on 19 December 2000 and subsequently reissued on 14 January 2004. The warrant was due to remain valid and effective until 12 March 2010. The arrest warrant pertains to Mr. Mellon's alleged involvement in a conspiracy to manipulate the share price of Regent Securities Co., Ltd. Mr. Mellon has informed the Company that he denies these allegations which are without substance.

 

On 29 January 2014 Rivington Street Holdings plc, a company of which Jim Mellon is a director, entered into a voluntary liquidation. The creditors are owed approximately £4 million, of which Mr. Mellon and his interests are owed £3.8 million.

 

On 3 January 2008, Bigsave Holdings plc, a company of which Jim Mellon was a director, entered into a voluntary liquidation. There were no unsatisfied creditors.

 

On 9 December 2005 Undervalued Assets Fund - Series One, a company of which Jim Mellon was a director, entered into a voluntary liquidation. There were no unsatisfied creditors.

 

On 8 April 2003, Regent Pacific Fund, a company of which Jim Mellon was a dirwector, entered into a voluntary liquidation. There were no unsatisfied creditors.

On 10 June 2002, UBQT Media plc, a company of which Jim Mellon was a director, entered into a voluntary liquidation. There were no unsatisfied creditors.

Asian Opportunity Fund 1998 - Series I commenced voluntary liquidation on 5 February 2008 pursuant to its Articles and Association. Jim Mellon was a director within the 12 month period preceding such date. There were no unsatisfied creditors.

 

Jim Mellon was also previously a director of Regent Global Fund and Undervalued Assets Greater China Fund Series III, both of which went into voluntary liquidation. These two funds were liquidated with the consent of shareholders as the directors recommended that due to a decline in the size of the funds, they were uneconomic. There were no unsatisfied creditors.

 

Mr. Mellon has confirmed that in relation to his appointment there is no further information which is required to be disclosed under paragraph (g) of Schedule Two to the AIM Rules.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAURASRVSABAAR
Date   Source Headline
12th Jul 20216:15 pmRNSUpdate on timetable for Change of Name
9th Jul 20214:00 pmRNSResult of EGM and Change of Name
7th Jul 20217:00 amRNSFurther Investment in South West Brands Limited
6th Jul 20217:00 amRNSInvestment in cannabis healthcare company- CiiTECH
5th Jul 20217:00 amRNSNew investment - European medical cannabis company
28th Jun 20217:30 amRNSSale of Shares in Portage Biotech
28th Jun 20217:00 amRNSFurther Investment in Little Green Pharma Ltd
22nd Jun 20213:30 pmRNSNotice of EGM & Proposed Change of Name
22nd Jun 20213:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
10th Jun 20217:00 amRNSPurchase of further shares in Little Green Pharma
1st Jun 20217:00 amRNSInvestee Company Update: Yooma Wellness Inc.
28th May 20217:00 amRNSInvestee Company Update: Little Green Pharma
29th Apr 20217:00 amRNSInvestee Company Update: Yooma Wellness
12th Apr 20219:00 amRNSSpecialist Appointed to Strengthen Team
7th Apr 20214:25 pmRNSCompletion of Sale of Investment in EMMAC
1st Apr 20217:00 amRNSNew Investment in Cannabis Cultivator Company
22nd Mar 20213:26 pmRNSInvestee Company Update: Yooma Wellness
18th Mar 20211:55 pmRNSInvestee Company Update: Yooma Wellness Inc.
15th Mar 20217:00 amRNSInvestee Company Update: Leap Gaming
11th Mar 20218:00 amRNSSale of Investments in Kanabo and Cellular Goods
10th Mar 20217:00 amRNSConditional Sale of Investment in EMMAC
8th Mar 202110:21 amRNSInvestee Update: Portage Biotech & Juvenescence
3rd Mar 20217:00 amRNSNew Corporate Presentation
2nd Mar 20212:06 pmRNSInvestee Update: EMMAC Life Sciences and Yooma
1st Mar 20217:00 amRNSNew Investment in Consumer Cannabinoid Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20217:15 amRNSInvestor Presentation
26th Feb 20217:00 amRNSCorporate Update
23rd Feb 20214:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Feb 20218:15 amRNSHolding(s) in Company
18th Feb 20212:05 pmRNSSecond Price Monitoring Extn
18th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20219:37 amRNSInvestee Company Update: Little Green Pharma Ltd
16th Feb 20212:00 pmRNSPrice Monitoring Extension
16th Feb 202112:20 pmRNSInvestment in Medical Cannabis Company
12th Feb 20217:00 amRNSNew Investment in Medical Cannabis Business
11th Feb 20213:44 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Feb 202110:33 amRNSInvestee Company Update: Yooma Corp.
2nd Feb 202111:09 amRNSInvestee Company Update: Leap Gaming
1st Feb 20217:00 amRNSInvestment - CBD Brand Business, South West Brands
29th Jan 202110:40 amRNSPlacing to raise £2.1 million
26th Jan 20214:12 pmRNSInvestee Company Update: EMMAC Life Sciences
26th Jan 20212:14 pmRNSInvestee Company Update: Yooma Corp.
20th Jan 202112:00 pmRNSInvestee Update: EMMAC Life Sciences & Yooma Corp.
16th Dec 20207:00 amRNSFurther Investment in EMMAC Life Sciences Group
10th Dec 20207:00 amRNSInterim Results
30th Nov 20207:00 amRNSEd McDermott Appointed to the Board of Leap Gaming
24th Nov 20207:00 amRNSInvestee Company Update: Yooma Corp.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.